1.100CAD-0.90%Mkt Cap: 54.42M $P/E: —2d ago
Arch Biopartners Inc., together with its subsidiaries, engages in the development of novel drugs for acute kidney injury and organ damage in Canada. It focuses on developing its lead drug candidate LSALT Peptide, which i…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap54.42M $
Enterprise Value51.64M $
Revenue (TTM)115.12K $
Gross Profit-351.16K $
Net Income (TTM)-1.13M $
Revenue/Share0.0015 USD
Last Price1.100 CAD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue448.55
P/S434.04
P/B-18.70
EPS (TTM)-0.04
EPS (Forward)—
52W Range
0.390052% of range1.750
52W High1.750 CAD
52W Low0.3900 CAD
Profitability
Gross Margin0.00%
Oper. Margin-1418.63%
EBITDA Margin0.00%
Profit Margin0.00%
ROE40.00%
ROA-1485.45%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-794.85K $
CapEx (TTM)—
FCF Margin-154.22%
FCF Yield-0.33%
Net Debt1.67M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.64
Current Ratio0.11
Quick Ratio0.11
Book Value/Sh-0.0540 CAD
Cash/Share0.0060 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateSep 13, 2000
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.67.93M
Float53.90M
Insiders18.30%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.01%
Shares Short5.67K
Short (prev mo.)40.55K
Technical
SMA 500.8576 (+28.3%)
SMA 2000.8514 (+29.2%)
Beta1.72
S&P 52W Chg18.16%
Avg Vol (30d)63.57K
Avg Vol (10d)59.92K
Technical Indicators
RSI (14)68.7
MACD0.0936
MACD Signal0.0768
MACD Hist.+0.0168
BB Upper1.167 CAD
BB Middle0.9335 CAD
BB Lower0.7003 CAD
BB Width49.96%
ATR (14)0.0854 CAD
Vol Ratio (20d)0.62x